When: October 1 @ 5:00 pm - 6:00 pm ET
A webinar on the most urgent international logistics challenges and issues facing life science companies today, especially regarding US-China interactions, future trends, and recommendations for life science leaders. Converge Consulting experts were joined by the VP of Supply Chain & Logistics from CG Oncology who shared her personal experience navigating the dynamics of US-China trade and logistics in previous roles.
Background
US life science companies face ongoing trade and logistical challenges to develop and produce their drug products in the global market. Issues include:
- Growing reliance on internationally manufactured API, particularly from China
- Increased regulatory and safety considerations
- National security considerations
- Global ocean and air freight considerations
Adding to the complexity, governments are increasingly using global trade as a component of their foreign policy. Those policy decisions may be out of industry control, but they have significant ramifications on life science supply chains. Right now, this is most notable in the volatile dynamic between the US and China.
Sandra Gutierrez
VP of Supply Chain & Logistics, CG Oncology
Sandra Gutierrez is an accomplished supply chain and project management leader with 20+ years of strategic and technical experience within pharmaceutical and biotechnology operations, as well as proven effective collaboration with research & development and sales & marketing. Prior to CG Oncology, Gutierrez served as VP of Commercial Supply Chain for Invivyd, as well as in supply chain, technical operations, and program management roles with FerGene, Stemline Therapeutics, Takeda Oncology, ARIAD Pharmaceuticals, Merck, the Schering-Plough Research Institute, and Bristol-Myers Squibb. She holds a Bachelor of Applied Science from Columbia Engineering and a MBA from Rutgers Business School.
Todd Applebaum
Managing Director, Converge Consulting
Todd Applebaum has supported many clients transitioning from clinical development to commercial production of Biologics, Pharmaceuticals, and Cell Therapies. Todd consults on business strategy, manufacturing, technical operations, the quality system, process development, operational strategy & execution, supply chain management, business process/workflow automation and IT enterprise solutions. Prior to starting Converge Consulting, he served as VP, Technical Operations at Ovascience, Inc., helping transition the company from research to commercial operations. Todd also held the role of VP, Research for the Healthcare and Life Science industries at Gartner, Inc. where his research focused on building patient outcomes-focused operations, the impact of personalized and precision medicines, global operations and network planning, track & trace technologies and operational & performance excellence. He has a BS in Industrial Engineering from General Motors Institute and an MBA from Carnegie Mellon University.
Mile Iliev
Senior Consultant, Converge Consulting
Mile Iliev has a background in clinical and commercial supply chain, operations, project management, data analytics, and financial management. Currently, Mile provides engagement management for emerging and established biopharmaceutical clients dealing with Supply Chain and Logistics challenges. Prior to Converge, he served as an advisor with a private health and lifestyle company, analyzing sales data and developing strategic insights using their in-house mobile platform. Mile has also conducted extensive market research, competitor analysis, and cost analyses to develop a dynamic 3-statement financial performance model, using the model to provide financial leverage recommendations and evaluate both new business opportunities and strategic partnerships. He earned his MBA at Babson College and holds a B.S. in International Economy and Business from St. Kliment Ohridski University in Prilep, Macedonia. Mile is proficient in Spanish, Serbo-Croatian and Bulgarian.